(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billion.

OpenAI Expects $70 Billion in Annualized Revenue by End of 2026
18:11

Goldman’s Top Leaders Set to Score More Than $500 Million With Special Bonus
19:53

SpaceX in Talks to Borrow $40 Billion to Buy Nvidia Chips
18:06